Cellular and molecular pathways to myocardial necrosis and replacement fibrosis

Heart Failure Reviews

Volumn 16, Issue 1, 2011, Pages 23-34

  Gandhi, Malay S ^a   Kamalov, German ^a   Shahbaz, Atta U ^a   Bhattacharya, Syamal K ^a   Ahokas, Robert A ^a   Sun, Yao ^a   Gerling, Ivan C ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Aldosteronism; Hypocalcemia; Hypomagnesemia; Hypozincemia; Intracellular calcium overloading; Mitochondria; Oxidative stress; Secondary hyperparathyroidism

Indexed keywords

ALDOSTERONE; AMLODIPINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOPHILIN D; PARATHYROID HORMONE; ZINC;

ARTICLE; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORTICOTROPIN RELEASE; GENE OVEREXPRESSION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE FILLING; HOMEOSTASIS; HUMAN; HYPERALDOSTERONISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MICROSCOPY; MITOCHONDRIAL PERMEABILITY; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCAR FORMATION; SECONDARY HYPERPARATHYROIDISM; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; UPREGULATION; ZINC DYSHOMEOSTASIS;

ALDOSTERONE; ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; HEART FAILURE; HUMANS; HYPERCALCIURIA; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; INTRACELLULAR CALCIUM-SENSING PROTEINS; MITOCHONDRIA; MYOCARDIUM; NECROSIS; NEPHROCALCINOSIS; OXIDATIVE STRESS; RENAL TUBULAR TRANSPORT, INBORN ERRORS; VENTRICULAR REMODELING;

EID: 78650972432     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-010-9169-3     Document Type: Article

References (115)

1. CA Beltrami N Finato M Rocco GA Feruglio C Puricelli E Cigola F Quaini EH Sonnenblick G Olivetti P Anversa 1994 Structural basis of end-stage failure in ischemic cardiomyopathy in humans Circulation 89 151 163 1:STN:280: DyaK2c7gvFSjuw%3D%3D 8281642
2. Cotran RS, Kumar V, Robbins SL (1989) The heart. In: Cotran RS, Kumar V, Robbins SL (eds) Robbins pathologic basis of disease, 4th edn. W B Saunders, Philadelphia, pp 597-656
3. M Park YT Shen V Gaussin GR Heyndrickx J Bartunek RR Resuello FF Natividad RN Kitsis DE Vatner SF Vatner 2009 Apoptosis predominates in nonmyocytes in heart failure Am J Physiol Heart Circ Physiol 297 H785 H791 1:CAS:528:DC%2BD1MXhtVahtrnF 19465551 10.1152/ajpheart.00310.2009
4. H Li A Ambade F Re 2009 Cutting edge: necrosis activates the NLRP3 inflammasome J Immunol 183 1528 1532 1:CAS:528:DC%2BD1MXoslCktbk%3D 19596994 10.4049/jimmunol.0901080
5. I Cohen P Rider Y Carmi A Braiman S Dotan MR White E Voronov MU Martin CA Dinarello RN Apte 2010 Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation Proc Natl Acad Sci U S A 107 2574 2579 1:CAS:528:DC%2BC3cXit1aksLg%3D 20133797 10.1073/pnas.0915018107
6. KT Weber 1989 Cardiac interstitium in health and disease: the fibrillar collagen network J Am Coll Cardiol 13 1637 1652 1:STN:280:DyaL1M3ls1elsg%3D%3D 2656824 10.1016/0735-1097(89)90360-4
7. J Ishii M Nomura Y Nakamura H Naruse Y Mori T Ishikawa T Ando H Kurokawa T Kondo Y Nagamura K Ezaki H Hishida 2002 Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure Am J Cardiol 89 691 695 1:CAS:528:DC%2BD38XhvVWkur4%3D 11897211 10.1016/S0002-9149(01)02341-4 (Pubitemid 34230565)
8. Y Kuwabara Y Sato T Miyamoto R Taniguchi T Matsuoka K Isoda K Yamane K Nishi H Fujiwara Y Takatsu 2007 Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes Circ J 71 1047 1051 1:CAS:528: DC%2BD2sXotlWms70%3D 17587709 10.1253/circj.71.1047 (Pubitemid 46998018)
9. WF Peacock IV T De Marco GC Fonarow D Diercks J Wynne FS Apple AH Wu 2008 Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2117 2126 1:CAS:528:DC%2BD1cXlvFCrsrk%3D 18480204 10.1056/NEJMoa0706824 (Pubitemid 351679598)
10. Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM, Batika PC, Prekates AA, Velissaris D, Kouris NT, Mytas DZ, Babalis DK, Karidis KS, Foussas SG (2009, Jan 19) Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol [Epub ahead of print]
11. C Löwbeer SA Gustafsson A Seeberger F Bouvier J Hulting 2004 Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction Scand J Clin Lab Invest 64 667 676 15513324 10.1080/00365510410003002 1:CAS:528: DC%2BD2cXotlOjtbs%3D (Pubitemid 39425306)
12. J Sukova P Ostadal P Widimsky 2007 Profile of patients with acute heart failure and elevated troponin I levels Exp Clin Cardiol 12 153 156 18650997
13. T Ilva J Lassus K Siirilä-Waris J Melin K Peuhkurinen K Pulkki MS Nieminen H Mustonen P Porela VP Harjola 2008 Clinical significance of cardiac troponins I and T in acute heart failure Eur J Heart Fail 10 772 779 1:CAS:528:DC%2BD1cXoslWktLY%3D 18599345 10.1016/j.ejheart.2008.06.009
14. Y Sato K Nishi R Taniguchi T Miyamoto R Fukuhara K Yamane S Saijyo Y Tanada E Yamamoto T Goto N Takahashi H Fujiwara Y Takatsu 2009 In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events J Cardiol 54 221 230 19782259 10.1016/j.jjcc.2009.05.007
15. WL Miller KA Hartman MF Burritt DE Grill AS Jaffe 2009 Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure J Am Coll Cardiol 54 1715 1721 1:CAS:528: DC%2BD1MXhsFait7rI 19850213 10.1016/j.jacc.2009.07.025
16. G Heusch P Kleinbongard D Böse B Levkau M Haude R Schulz R Erbel 2009 Coronary microembolization: from bedside to bench and back to bedside Circulation 120 1822 1836 19884481 10.1161/CIRCULATIONAHA.109.888784
17. J Chen JL Mehta 2006 Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease Curr Hypertens Rep 8 139 143 1:CAS:528:DC%2BD28XlsVCht78%3D 16672147 10.1007/s11906-006-0010-2
18. P Delafontaine M Akao 2006 Angiotensin II as candidate of cardiac cachexia Curr Opin Clin Nutr Metab Care 9 220 224 1:CAS:528:DC%2BD28Xls1Sksbw%3D 16607120 10.1097/01.mco.0000222103.29009.70 (Pubitemid 44097832)
19. LB Tan JE Jalil R Pick JS Janicki KT Weber 1991 Cardiac myocyte necrosis induced by angiotensin II Circ Res 69 1185 1195 1:CAS:528:DyaK38Xlt1agsw%3D%3D 1834362
20. IJ Benjamin JE Jalil LB Tan K Cho KT Weber WA Clark 1989 Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ Res 65 657 670 1:CAS:528:DyaL1MXlsFWgurw%3D 2527639
21. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure J Clin Invest 117 2431 2444 1:CAS:528:DC%2BD2sXhtVCms7vO 17694179 10.1172/JCI31060 (Pubitemid 47494345)
22. MJ Brown DC Brown MB Murphy 1983 Hypokalemia from beta2-receptor stimulation by circulating epinephrine N Engl J Med 309 1414 1419 1:CAS:528:DyaL2cXmt1eisQ%3D%3D 6314140 10.1056/NEJM198312083092303
23. JL Reid KF Whyte AD Struthers 1986 Epinephrine-induced hypokalemia: the role of beta adrenoceptors Am J Cardiol 57 23F 27F 1:CAS:528:DyaL28XktlKisLs%3D 3010693 10.1016/0002-9149(86)90884-2
24. O Hansen BW Johansson P Nilsson-Ehle 1990 Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade Angiology 41 175 188 1:STN:280:DyaK3c7nvVOjtA%3D%3D 1968731 10.1177/ 000331979004100302
25. F Carlstedt L Lind L Wide B Lindahl A Hänni J Rastad S Ljunghall 1997 Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department Eur J Clin Invest 27 977 981 1:STN:280:DyaK1c7islaksw%3D%3D 9466123 10.1046/j.1365-2362.1997. 2310778.x
26. F Carlstedt L Lind J Rastad H Stjernstrom L Wide S Ljunghall 1998 Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients Eur J Clin Invest 28 898 903 1:CAS:528:DyaK1cXotVGgt78%3D 9824432 10.1046/j.1365-2362.1998.00391.x (Pubitemid 28521580)
27. S Javadov M Karmazyn N Escobales 2009 Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases J Pharmacol Exp Ther 330 670 678 1:CAS:528:DC%2BD1MXhtVyitL7E 19509316 10.1124/jpet.109.153213
28. M Chvapil JA Owen 1977 Effect of zinc on acute and chronic isoproterenol induced heart injury J Mol Cell Cardiol 9 151 159 1:CAS:528:DyaE2sXhtVWjsLo%3D 839549 10.1016/0022-2828(77)90046-3 (Pubitemid 8024772)
29. G Chanoit S Lee J Xi M Zhu RA McIntosh RA Mueller EA Norfleet Z Xu 2008 Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3β Am J Physiol Heart Circ Physiol 295 H1227 H1233 1:CAS:528:DC%2BD1cXhtFCgtL7F 18660440 10.1152/ajpheart.00610.2008
30. AP Halestrap 2006 Calcium, mitochondria and reperfusion injury: a pore way to die Biochem Soc Trans 34 Pt 2 232 237 1:CAS:528:DC%2BD28Xis1ersrk%3D 16545083
31. T Nakagawa S Shimizu T Watanabe O Yamaguchi K Otsu H Yamagata H Inohara T Kubo Y Tsujimoto 2005 Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 652 658 1:CAS:528:DC%2BD2MXislCnu7c%3D 15800626 10.1038/nature03317 (Pubitemid 40488558)
32. CP Baines RA Kaiser NH Purcell NS Blair H Osinska MA Hambleton EW Brunskill MR Sayen RA Gottlieb GW Dorn J Robbins JD Molkentin 2005 Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 658 662 1:CAS:528:DC%2BD2MXislCms7k%3D 15800627 10.1038/nature03434 (Pubitemid 40488559)
33. G Karagulova Y Yue A Moreyra M Boutjdir I Korichneva 2007 Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms J Pharmacol Exp Ther 321 517 525 1:CAS:528:DC%2BD2sXltFehtLc%3D 17322024 10.1124/jpet.107.119644 (Pubitemid 46624490)
34. G Heusch K Boengler R Schulz 2010 Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection Basic Res Cardiol 105 151 154 20066536 10.1007/s00395-009-0080-9
35. Y Tsujimoto S Shimizu 2007 Role of the mitochondrial membrane permeability transition in cell death Apoptosis 12 835 840 1:CAS:528: DC%2BD2sXksFamsbg%3D 17136322 10.1007/s10495-006-0525-7 (Pubitemid 46653286)
36. SP LaGuardia BK Dockery SK Bhattacharya MD Nelson LD Carbone KT Weber 2006 Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure Am J Med Sci 332 112 118 16969139 10.1097/00000441-200609000-00003 (Pubitemid 44401230)
37. M Arroyo SP LaGuardia SK Bhattacharya MD Nelson PL Johnson LD Carbone KP Newman KT Weber 2006 Micronutrients in African-Americans with decompensated and compensated heart failure Transl Res 148 301 308 1:CAS:528:DC%2BD28Xht12ktbvK 17162251 10.1016/j.trsl.2006.08.003 (Pubitemid 44880038)
38. S Alsafwah SP LaGuardia MD Nelson DL Battin KP Newman LD Carbone KT Weber 2008 Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure Am J Med Sci 335 292 297 18414068 10.1097/MAJ.0b013e318167b0bd (Pubitemid 351548648)
39. O Oster 1993 Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy Clin Chim Acta 214 209 218 1:STN:280:DyaK3s3jtVOisQ%3D%3D 8472386 10.1016/0009-8981(93)90112-H (Pubitemid 23102291)
40. S Ripa R Ripa S Giustiniani 1998 Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies Minerva Med 89 397 403 1:STN:280:DyaK1M3ivFWgsQ%3D%3D 10212663
41. G Topuzoglu AR Erbay AB Karul N Yensel 2003 Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy Biol Trace Elem Res 95 11 17 1:CAS:528:DC%2BD3sXoslCjsL8%3D 14555795 10.1385/BTER:95:1:11 (Pubitemid 37386643)
42. E Salehifar M Shokrzadeh A Ghaemian S Aliakbari SS Saeedi Saravi 2008 The study of Cu and Zn serum levels in idiopathic dilated cardiomyopathy (IDCMP) patients and its comparison with healthy volunteers Biol Trace Elem Res 125 97 108 1:CAS:528:DC%2BD1cXhtFKhs7bP 18716717 10.1007/s12011-008-8151-6
43. A Cénac M Simonoff A Djibo 1996 Nutritional status and plasma trace elements in peripartum cardiomyopathy. A comparative study in Niger J Cardiovasc Risk 3 483 487 9100082 10.1097/00043798-199612000-00001 (Pubitemid 27142215)
44. AH Lee RL Mull GF Keenan PE Callegari MK Dalinka HJ Eisen DM Mancini VJ DiSesa MF Attie 1994 Osteoporosis and bone morbidity in cardiac transplant recipients Am J Med 96 35 41 1:STN:280:DyaK2c7js1Gjtg%3D%3D 8304361 10.1016/0002-9343(94)90113-9 (Pubitemid 24043650)
45. E Shane D Mancini K Aaronson SJ Silverberg MJ Seibel V Addesso DJ McMahon 1997 Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure Am J Med 103 197 207 1:STN:280:DyaK2svmt1arsA%3D%3D 9316552 10.1016/S0002-9343(97)00142-3 (Pubitemid 27413402)
46. CR Díaz-Vélez S García-Castiñeiras E Mendoza-Ramos E Hernández-López 1996 Increased malondialdehyde in peripheral blood of patients with congestive heart failure Am Heart J 131 146 152 8554002 10.1016/S0002-8703(96)90063-0 (Pubitemid 26021377)
47. M Keith A Geranmayegan MJ Sole R Kurian A Robinson AS Omran KN Jeejeebhoy 1998 Increased oxidative stress in patients with congestive heart failure J Am Coll Cardiol 31 1352 1356 1:STN:280:DyaK1c3ktVyltg%3D%3D 9581732 10.1016/S0735-1097(98)00101-6 (Pubitemid 28219127)
48. J Campolo R De Maria R Caruso R Accinni F Turazza M Parolini E Roubina B De Chiara G Cighetti M Frigerio E Vitali O Parodi 2007 Blood glutathione as independent marker of lipid peroxidation in heart failure Int J Cardiol 117 45 50 16884794 10.1016/j.ijcard.2006.04.065 (Pubitemid 46399970)
49. Y Sun FJA Ramires KT Weber 1997 Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion Cardiovasc Res 35 138 147 1:CAS:528:DyaK2sXlvFejt7Y%3D 9302358 10.1016/S0008-6363(97)00097-7 (Pubitemid 27374751)
50. Y Sun J Zhang JQ Zhang FJA Ramires 2000 Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats Hypertension 35 1078 1084 1:CAS:528:DC%2BD3cXjvV2qtr4%3D 10818068
51. EL Schiffrin 1995 Endothelin: potential role in hypertension and vascular hypertrophy Hypertension 25 1135 1143 1:CAS:528:DyaK2MXmvVChurc%3D 7768553
52. KT Weber 2001 Aldosterone in congestive heart failure N Engl J Med 345 1689 1697 1:CAS:528:DC%2BD3MXovFKjtbw%3D 11759649 10.1056/NEJMra000050 (Pubitemid 33126826)
53. M Young M Fullerton R Dilley J Funder 1994 Mineralocorticoids, hypertension, and cardiac fibrosis J Clin Invest 93 2578 2583 1:CAS:528:DyaK2cXlsFClsbs%3D 8200995 10.1172/JCI117269
54. A Garnier JK Bendall S Fuchs B Escoubet F Rochais J Hoerter J Nehme ML Ambroisine N De Angelis G Morineau P d'Estienne R Fischmeister C Heymes F Pinet C Delcayre 2004 Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice Circulation 110 1819 1825 1:CAS:528:DC%2BD2cXnslems70%3D 15364804 10.1161/01.CIR.0000142858. 44680.27 (Pubitemid 39299224)
55. MJ Somers K Mavromatis ZS Galis DG Harrison 2000 Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt Circulation 101 1722 1728 1:CAS:528:DC%2BD3cXjtF2ntr0%3D 10758056
56. Q Pu MF Neves A Virdis RM Touyz EL Schiffrin 2003 Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling Hypertension 42 49 55 1:CAS:528:DC%2BD3sXkvVKmtrk%3D 12782645 10.1161/01.HYP.0000078357.92682.EC (Pubitemid 36849598)
57. A Virdis MF Neves F Amiri E Viel RM Touyz EL Schiffrin 2002 Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 504 510 1:CAS:528:DC%2BD38Xntlams7Y%3D 12364354 10.1161/01.HYP.0000034738.79310.06
58. Y Sun J Zhang L Lu SS Chen MT Quinn KT Weber 2002 Aldosterone-induced inflammation in the rat heart. Role of oxidative stress Am J Pathol 161 1773 1781 1:CAS:528:DC%2BD38XptV2gtLk%3D 12414524
59. MS Gandhi PA Deshmukh G Kamalov T Zhao W Zhao JT Whaley JR Tichy SK Bhattacharya RA Ahokas Y Sun IC Gerling KT Weber 2008 Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism J Cardiovasc Pharmacol 52 245 252 1:CAS:528:DC%2BD1cXhtFers73K 18806605 10.1097/FJC.0b013e3181833eb8
60. A Fleckenstein M Frey G Fleckenstein-Grun 1983 Consequences of uncontrolled calcium entry and its prevention with calcium antagonists Eur Heart J 4 Suppl H 43 50 1:CAS:528:DyaL2cXpsF2iug%3D%3D 6662132
61. VS Chhokar Y Sun SK Bhattacharya RA Ahokas LK Myers Z Xing RA Smith IC Gerling KT Weber 2005 Hyperparathyroidism and the calcium paradox of aldosteronism Circulation 111 871 878 1:CAS:528:DC%2BD2MXhtlait7Y%3D 15710759 10.1161/01.CIR.0000155621.10213.06 (Pubitemid 40279888)
62. 2 in peripheral blood mononuclear cells Circulation 111 51 57 1:CAS:528:DC%2BD2cXhtFeisLrK 15611366 10.1161/01.CIR.0000151516.84238.37 (Pubitemid 40070843)
63. RA Ahokas KJ Warrington IC Gerling Y Sun LA Wodi PA Herring L Lu SK Bhattacharya AE Postlethwaite KT Weber 2003 Aldosteronism and peripheral blood mononuclear cell activation. A neuroendocrine-immune interface Circ Res 93 e124 e135 1:CAS:528:DC%2BD3sXoslyku7w%3D 14576195 10.1161/01.RES.0000102404.81461.25
64. VS Chhokar Y Sun SK Bhattacharya RA Ahokas LK Myers Z Xing RA Smith IC Gerling KT Weber 2004 Loss of bone minerals and strength in rats with aldosteronism Am J Physiol Heart Circ Physiol 287 H2023 H2026 1:CAS:528:DC%2BD2cXhtVaqtr%2FF 15475529 10.1152/ajpheart.00477.2004 (Pubitemid 39430739)
65. T Fujita GM Palmieri 2000 Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload J Bone Miner Metab 18 109 125 1:CAS:528:DC%2BD3cXkslylsLg%3D 10783844 10.1007/s007740050101
66. G Kamalov RA Ahokas W Zhao PL Johnson AU Shahbaz SK Bhattacharya Y Sun IC Gerling KT Weber 2010 Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism Am J Physiol Heart Circ Physiol 298 H385 H394 1:CAS:528:DC%2BC3cXhvVyltL0%3D 19915175 10.1152/ajpheart.00593.2009
67. KD Goodwin RA Ahokas SK Bhattacharya Y Sun IC Gerling KT Weber 2006 Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements Am J Med Sci 332 73 78 16909053 10.1097/00000441-200608000-00004
68. A Vidal Y Sun SK Bhattacharya RA Ahokas IC Gerling KT Weber 2006 Calcium paradox of aldosteronism and the role of the parathyroid glands Am J Physiol Heart Circ Physiol 290 H286 H294 1:CAS:528:DC%2BD28XhsVKju7o%3D 16373592 10.1152/ajpheart.00535.2005
69. Y Selektor RA Ahokas SK Bhattacharya Y Sun IC Gerling KT Weber 2008 Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism Am J Med Sci 335 105 110 18277117 10.1097/MAJ.0b013e318134f013 (Pubitemid 351253405)
70. M Thomas A Vidal SK Bhattacharya RA Ahokas Y Sun IC Gerling KT Weber 2007 Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone Am J Physiol Heart Circ Physiol 293 H2361 H2366 1:CAS:528:DC%2BD2sXht1WlurfM 17616752 10.1152/ajpheart.00200.2007 (Pubitemid 47605882)
71. 65Zinc translocation in a rat model of chronic aldosteronism J Cardiovasc Pharmacol 51 359 364 1:CAS:528:DC%2BD1cXltVWgu74%3D 18427278 10.1097/FJC.0b013e318165b96e (Pubitemid 351572234)
72. L Aureli M Gioia I Cerbara S Monaco GF Fasciglione S Marini P Ascenzi A Topai M Coletta 2008 Structural bases for substrate and inhibitor recognition by matrix metalloproteinases Curr Med Chem 15 2192 2222 1:CAS:528: DC%2BD1MXisFCksbg%3D 18781944 10.2174/092986708785747490
73. G Kamalov PA Deshmukh NY Baburyan MS Gandhi PL Johnson RA Ahokas SK Bhattacharya Y Sun IC Gerling KT Weber 2009 Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism J Cardiovasc Pharmacol 53 414 423 1:CAS:528:DC%2BD1MXmtVOns7s%3D 19333130 10.1097/FJC.0b013e3181a15e77
74. J Wang Y Song L Elsherif Z Song G Zhou SD Prabhu JT Saari L Cai 2006 Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation Circulation 113 544 554 1:CAS:528:DC%2BD28XmvVSgsQ%3D%3D 16432057 10.1161/CIRCULATIONAHA.105.537894
75. K Lossnitzer J Janke B Hein M Stauch A Fleckenstein 1975 Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster Recent Adv Stud Cardiac Struct Metab 6 207 217 1:CAS:528:DyaE2MXmtVCms7g%3D 1197882
76. SK Bhattacharya PL Johnson JH Thakar 1993 Reversal of impaired oxidative phosphorylation and calcium overloading in the in vitro cardiac mitochondria of CHF-146 dystrophic hamsters with hereditary muscular dystrophy J Neurol Sci 120 180 186 1:CAS:528:DyaK2cXis1Ogu7o%3D 8138808 10.1016/0022-510X(93)90271-Y (Pubitemid 24040597)
77. GM Palmieri DF Nutting SK Bhattacharya TE Bertorini JC Williams 1981 Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris J Clin Invest 68 646 654 1:CAS:528:DyaL3MXls1Klsbk%3D 7276164 10.1172/JCI110299
78. SK Bhattacharya GM Palmieri TE Bertorini DF Nutting 1982 The effects of diltiazem in dystrophic hamsters Muscle Nerve 5 73 78 1:CAS:528: DyaL38XhslChsLs%3D 7057811 10.1002/mus.880050114
79. AJ Crawford SK Bhattacharya 1987 Excessive intracellular zinc accumulation in cardiac and skeletal muscles of dystrophic hamsters Exp Neurol 95 265 276 1:CAS:528:DyaL2sXhtlKgur0%3D 3803514 10.1016/0014-4886(87)90137-3 (Pubitemid 17017926)
80. G Kamalov RA Ahokas W Zhao T Zhao AU Shahbaz PL Johnson SK Bhattacharya Y Sun IC Gerling KT Weber 2010 Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism J Cardiovasc Pharmacol 55 248 254 1:CAS:528:DC%2BC3cXktFOmt7g%3D 20051880 10.1097/FJC.0b013e3181cf0090
81. RN Khouzam DA Dishmon V Farah SD Flax LD Carbone KT Weber 2006 Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure Am J Med Sci 331 30 34 16415661 10.1097/00000441-200601000-00009 (Pubitemid 43177513)
82. E Rossi C Sani F Perazzoli MC Casoli A Negro C Dotti 1995 Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas Am J Hypertens 8 884 893 1:CAS:528:DyaK2MXoslGrt7s%3D 8541003 10.1016/0895-7061(95)00182-O
83. NH Bell A Greene S Epstein MJ Oexmann S Shaw J Shary 1985 Evidence for alteration of the vitamin D-endocrine system in blacks J Clin Invest 76 470 473 1:CAS:528:DyaL2MXltlGqu74%3D 3839801 10.1172/JCI111995 (Pubitemid 15227507)
84. BP Sawaya MC Monier-Faugere P Ratanapanichkich R Butros PJ Wedlund P Fanti 2002 Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism Clin Nephrol 57 51 55 1:CAS:528: DC%2BD38Xht1ylu7Y%3D 11837801
85. R Horton EG Biglieri 1962 Effect of aldosterone on the metabolism of magnesium J Clin Endocrinol Metab 22 1187 1192 1:CAS:528:DyaF3sXnsFKqtw%3D%3D 13964048 10.1210/jcem-22-12-1187
86. JW Conn 1963 Aldosteronism in man. Some clinical and climatological aspects. Part I JAMA 183 775 781 1:STN:280:DyaF383hsVGktg%3D%3D 14022603
87. JW Conn 1963 Aldosteronism in man. Some clinical and climatological aspects. Part II JAMA 183 871 878 1:CAS:528:DyaF3sXkt12ku7s%3D 14022604
88. JL Garcia Zozaya M Padilla Viloria 1997 Alterations of calcium, magnesium, and zinc in essential hypertension: their relation to the renin-angiotensin-aldosterone system [Spanish] Invest Clin 38 Suppl 2 27 40 9471228
89. S Tubek 2005 Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension Biol Trace Elem Res 107 89 99 1:CAS:528:DC%2BD2MXhtFGkt7nO 16217134 10.1385/BTER:107:2:089
90. A Golik D Modai Z Averbukh M Sheffy A Shamis N Cohen U Shaked E Dolev 1990 Zinc metabolism in patients treated with captopril versus enalapril Metabolism 39 665 667 1:STN:280:DyaK3czgvFGqsQ%3D%3D 2195291 10.1016/0026-0495(90)90098-W (Pubitemid 20198256)
91. A Golik R Zaidenstein V Dishi A Blatt N Cohen G Cotter S Berman J Weissgarten 1998 Effects of captopril and enalapril on zinc metabolism in hypertensive patients J Am Coll Nutr 17 75 78 1:CAS:528:DyaK1cXhtFSiu7g%3D 9477394
92. KS Prabhu F Zamamiri-Davis JB Stewart JT Thompson LM Sordillo CC Reddy 2002 Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-κB in up-regulation Biochem J 366 Pt 1 203 209 1:CAS:528:DC%2BD3sXptFOht7g%3D 12006087
93. AS Reddi JS Bollineni 2001 Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats Kidney Int 59 1342 1353 1:CAS:528:DC%2BD3MXjtVOhtL4%3D 11260395 10.1046/j.1523-1755.2001. 0590041342.x (Pubitemid 32281222)
94. R Moreno-Reyes D Egrise J Neve JL Pasteels A Schoutens 2001 Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia J Bone Miner Res 16 1556 1563 1:CAS:528: DC%2BD3MXmtVOhurs%3D 11499879 10.1359/jbmr.2001.16.8.1556
95. K Venardos G Harrison J Headrick A Perkins 2004 Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion J Trace Elem Med Biol 18 81 88 1:CAS:528:DC%2BD2cXhtVentr7J 15487768 10.1016/j.jtemb.2004.01.001 (Pubitemid 39285969)
96. Q Wu K Huang H Xu 2003 Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta J Inorg Biochem 94 301 306 1:CAS:528:DC%2BD3sXitlWrs7w%3D 12667700 10.1016/S0162-0134(03)00058-8 (Pubitemid 36349497)
97. Q Wu K Huang 2004 Effect of long-term Se deficiency on the antioxidant capacities of rat vascular tissue Biol Trace Elem Res 98 73 84 1:CAS:528:DC%2BD2cXjt1Oqu7c%3D 15051902 10.1385/BTER:98:1:73 (Pubitemid 38526634)
98. P Faure O Ramon A Favier S Halimi 2004 Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients Eur J Clin Invest 34 475 481 1:CAS:528:DC%2BD2cXnt1SqsLg%3D 15255784 10.1111/j.1365-2362.2004.01362.x (Pubitemid 39049852)
99. RA Quercia S Korn D O'Neill JE Dougherty M Ludwig R Schweizer R Sigman 1984 Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition Clin Pharm 3 531 535 1:STN:280: DyaL2M%2FisFynsw%3D%3D 6435941
100. N Hatanaka H Nakaden Y Yamamoto S Matsuo T Fujikawa S Matsusue 2000 Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite Nutrition 16 22 26 1:CAS:528:DC%2BD3cXltVKguw%3D%3D 10674230 10.1016/S0899-9007(99)00183-5 (Pubitemid 30050720)
101. SL Weiss JK Evenson KM Thompson RA Sunde 1996 The selenium requirement for glutathione peroxidase mRNA level is half of the selenium requirement for glutathione peroxidase activity in female rats J Nutr 126 2260 2267 1:CAS:528:DyaK28XlsF2lurs%3D 8814215
102. YM Xia KE Hill RF Burk 1989 Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood J Nutr 119 1318 1326 1:CAS:528: DyaL1MXmtlWisrY%3D 2795246
103. AM van Rij CD Thomson JM McKenzie MF Robinson 1979 Selenium deficiency in total parenteral nutrition Am J Clin Nutr 32 2076 2085 114045
104. WC Reeves SP Marcuard SE Willis A Movahed 1989 Reversible cardiomyopathy due to selenium deficiency JPEN J Parenter Enteral Nutr 13 663 665 1:STN:280:DyaK3c7jsVaisw%3D%3D 2614867 10.1177/0148607189013006663
105. JF Sullivan AJ Blotcky MM Jetton HK Hahn RE Burch 1979 Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases J Nutr 109 1432 1437 1:CAS:528:DyaE1MXltlylsb8%3D 458498
106. J Koch EA Neal MJ Schlott YL Garcia-Shelton MF Chan KE Weaver JP Cello 1996 Zinc levels and infections in hospitalized patients with AIDS Nutrition 12 515 518 1:STN:280:DyaK2s%2Fjt1anuw%3D%3D 8878145 10.1016/S0899-9007(96)00173-6 (Pubitemid 26299992)
107. M van Lettow AD Harries JJ Kumwenda EE Zijlstra TD Clark TE Taha RD Semba 2004 Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi BMC Infect Dis 4 61 15613232 10.1186/1471-2334-4-61 (Pubitemid 41363775)
108. BM Dworkin WS Rosenthal GP Wormser L Weiss M Nunez C Joline A Herp 1988 Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex Biol Trace Elem Res 15 167 177 1:STN:280:DyaK3M%2FgtFahtg%3D%3D 2484515 10.1007/BF02990135
109. AL Kavanaugh-McHugh A Ruff E Perlman N Hutton J Modlin S Rowe 1991 Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome JPEN J Parenter Enteral Nutr 15 347 349 1:STN:280:DyaK3MzisFekug%3D%3D 1865554 10.1177/0148607191015003347
110. JK Jarvis GD Miller 2002 Overcoming the barrier of lactose intolerance to reduce health disparities J Natl Med Assoc 94 55 66 11853047
111. AJ Cohen FJ Roe 2000 Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt Food Chem Toxicol 38 237 253 1:CAS:528:DC%2BD3cXhslamsrw%3D 10717363 10.1016/S0278- 6915(99)00145-3 (Pubitemid 30136274)
112. B Teucher JR Dainty CA Spinks G Majsak-Newman DJ Berry JA Hoogewerff RJ Foxall J Jakobsen KD Cashman A Flynn SJ Fairweather-Tait 2008 Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women J Bone Miner Res 23 1477 1485 1:CAS:528:DC%2BD1cXhtFSlurvE 18410231 10.1359/jbmr.080408
113. S van Diepen SR Majumdar JA Bakal FA McAlister JA Ezekowitz 2008 Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16, 294 patients Circulation 118 1946 1952 18936331 10.1161/CIRCULATIONAHA.108. 784009
114. LD Carbone JD Cross SH Raza AJ Bush RJ Sepanski S Dhawan BQ Khan M Gupta K Ahmad RN Khouzam DA Dishmon JP Nesheiwat MA Hajjar WA Chishti W Nasser M Khan CR Womack T Cho AR Haskin KT Weber 2008 Fracture risk in men with congestive heart failure. Risk reduction with spironolactone J Am Coll Cardiol 52 135 138 18598893 10.1016/j.jacc.2008.03.039 (Pubitemid 351885442)
115. S Alsafwah SP LaGuardia M Arroyo BK Dockery SK Bhattacharya RA Ahokas KP Newman 2007 Congestive heart failure is a systemic illness. A role for minerals and micronutrients Clin Med Res 5 238 243 1:CAS:528:DC%2BD1cXntFCrtL4%3D 18367709 10.3121/cmr.2007.737 (Pubitemid 351731693)